LB Pharmaceuticals Inc (LBRX)

LB Pharmaceuticals Inc (LBRX) is a healthcare company (biotechnology) based in the United States. The share price is $39.91, down 7.16% on the day, which values the company at $1.29B. Price as of 17 Nov 2026, 17:28 UTC, from Yahoo Finance.

Key facts

Share price
$39.91−7.16% today
Market value
$1.29B
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

LB Pharmaceuticals Inc in more detail

LBRX trades at -7.0× next year's expected earnings.

In its favour: More cash than debt.

3 of the superinvestors tracked here hold LBRX, including Peter Kolchinsky (0.6% of the portfolio), Andrew Spokes (0.1% of the portfolio), Julian and Felix Baker (0.0% of the portfolio).

Superinvestors holding LBRX

3 of the investors tracked here report a position in their latest 13F filing.

LB Pharmaceuticals Inc (LBRX): questions and answers

What is LB Pharmaceuticals Inc's market cap?

LB Pharmaceuticals Inc is valued at $1.29B at a share price of $39.91.

Does LBRX pay a dividend?

LB Pharmaceuticals Inc does not currently pay a regular dividend.

Which famous investors own LBRX?

In their latest quarterly filings, Peter Kolchinsky (0.6% of the portfolio), Andrew Spokes (0.1% of the portfolio), Julian and Felix Baker (0.0% of the portfolio) hold LBRX. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “LB Pharmaceuticals Inc (LBRX) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/LBRX

Underlying data: Yahoo Finance; company filings with the SEC.